Supplementary Table S7 from A Phase Ib Study of Onvansertib, a Novel Oral PLK1 Inhibitor, in Combination Therapy for Patients with Relapsed or Refractory Acute Myeloid Leukemia
收藏NIAID Data Ecosystem2026-04-25 收录
数据链接：
官方服务：
资源简介：
Detailed list of variants identified by targeted-NGS
创建时间：
2020-12-01
